Heparin is an anticoagulant, or blood thinner, that is used to prevent the formation of harmful blood clots. It can be used to treat a variety of conditions, including some types of heart attack, atrial fibrillation, or a pulmonary embolism. Heparin works by activating antithrombin, a natural anticoagulant that stops the clotting process.
Heparin is widely used globally. In the United States, it is one of the most frequently prescribed medication. It is also used in many countries in Europe and Asia. Globally, it is used in the prevention and treatment of a variety of cardiovascular, thromboembolic, and other conditions.
The global Heparin market was valued at US$ 2262.9 million in 2022 and is anticipated to reach US$ 5382.1 million by 2029, witnessing a CAGR of 12.6% during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
A detailed market research report on Global Heparin Market available at: https://www.themarketreports.com/report/global-heparin-market-research-report
This report aims to provide a comprehensive presentation of the global market for Heparin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Heparin.
Global key players of Heparin include Shenzhen Hepalink Pharmaceutical, Yantai Dongcheng Pharmaceutical, Nanjing King-friend Biochemical Pharmaceutical, Pfizer, Hebei Changshan Biochemical Pharmaceutical, etc. The top five manufacturers hold a share about 54%. China is dominating the global Heparin market, has a share over 65% in terms of production. Europe and Asia-Pacific are the two largest market, both having a share about 34%, followed by North America, with a share about 30 percent.
Ask for more details or sample of this report at: https://www.themarketreports.com/report/ask-your-query/1364594
The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479